Lekha Dinesh Kumar

600 total citations
21 papers, 430 citations indexed

About

Lekha Dinesh Kumar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lekha Dinesh Kumar has authored 21 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Lekha Dinesh Kumar's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers) and RNA Interference and Gene Delivery (4 papers). Lekha Dinesh Kumar is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers) and RNA Interference and Gene Delivery (4 papers). Lekha Dinesh Kumar collaborates with scholars based in India, Spain and Australia. Lekha Dinesh Kumar's co-authors include Alan R. Clarke, M. Kathirvel, Javaregowda Nagaraju, Anindya Goswami, Debaraj Mukherjee, Bilal Rah, Debasis Nayak, Reyaz ur Rasool, Syed Khalid Yousuf and Aviral Kumar and has published in prestigious journals such as Advanced Drug Delivery Reviews, Scientific Reports and Nanoscale.

In The Last Decade

Lekha Dinesh Kumar

21 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lekha Dinesh Kumar India 12 252 92 53 51 44 21 430
Hélène Bobichon France 11 330 1.3× 85 0.9× 105 2.0× 41 0.8× 60 1.4× 25 588
Jordi Pijuan Spain 9 251 1.0× 64 0.7× 86 1.6× 30 0.6× 34 0.8× 15 533
David F. Moreno Spain 9 316 1.3× 58 0.6× 81 1.5× 25 0.5× 36 0.8× 19 577
Hongmei Wu China 15 422 1.7× 70 0.8× 69 1.3× 54 1.1× 31 0.7× 36 578
Wenyan Xu China 14 421 1.7× 113 1.2× 57 1.1× 61 1.2× 35 0.8× 37 627
Jinwei Wu China 11 269 1.1× 61 0.7× 127 2.4× 39 0.8× 50 1.1× 20 487
Anaïs Panosa Spain 7 247 1.0× 58 0.6× 88 1.7× 43 0.8× 25 0.6× 10 523
Xiaoyuan Zhang China 13 350 1.4× 62 0.7× 51 1.0× 31 0.6× 55 1.3× 37 629
Chenyang Li China 13 324 1.3× 87 0.9× 97 1.8× 52 1.0× 31 0.7× 47 629
Kyu-Yeon Han United States 11 280 1.1× 105 1.1× 70 1.3× 24 0.5× 19 0.4× 14 562

Countries citing papers authored by Lekha Dinesh Kumar

Since Specialization
Citations

This map shows the geographic impact of Lekha Dinesh Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lekha Dinesh Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lekha Dinesh Kumar more than expected).

Fields of papers citing papers by Lekha Dinesh Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lekha Dinesh Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lekha Dinesh Kumar. The network helps show where Lekha Dinesh Kumar may publish in the future.

Co-authorship network of co-authors of Lekha Dinesh Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Lekha Dinesh Kumar. A scholar is included among the top collaborators of Lekha Dinesh Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lekha Dinesh Kumar. Lekha Dinesh Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cordani, Marco, et al.. (2025). Non-coding RNAs as mediators of epithelial to mesenchymal transition in metastatic colorectal cancers. Cellular Signalling. 127. 111605–111605. 1 indexed citations
2.
Chakraborty, Souneek, Aviral Kumar, Yedukondalu Nalli, et al.. (2024). Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression. Biochemical Pharmacology. 223. 116126–116126. 3 indexed citations
3.
Beevi, Syed Sultan, et al.. (2024). MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways. Cell Communication and Signaling. 22(1). 100–100. 4 indexed citations
4.
Menon, Nandini, et al.. (2024). Small-molecule inhibitors of WNT signalling in cancer therapy and their links to autophagy and apoptosis. European Journal of Pharmacology. 986. 177137–177137. 1 indexed citations
5.
Cordani, Marco, et al.. (2023). Retinoblastoma: present scenario and future challenges. Cell Communication and Signaling. 21(1). 226–226. 33 indexed citations
6.
Singh, Ankit, et al.. (2022). Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy. Frontiers in Nanotechnology. 4. 8 indexed citations
7.
Jain, Poonam, Aviral Kumar, Ashok Kumar Jangid, et al.. (2021). Inulin coated Mn3O4 nanocuboids coupled with RNA interference reverse intestinal tumorigenesis in Apc knockout murine colon cancer models. Nanomedicine Nanotechnology Biology and Medicine. 40. 102504–102504. 13 indexed citations
8.
Kumar, Aviral, et al.. (2021). Quantitative proteome profiling stratifies fibroepithelial lesions of the breast. Oncotarget. 12(5). 507–518. 10 indexed citations
9.
Kumar, Aviral, et al.. (2021). Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models. Nanoscale. 14(2). 492–505. 24 indexed citations
10.
Nair, Rekha A., et al.. (2020). MicroRNA Signatures in Blood or Bone Marrow Distinguish Subtypes of Pediatric Acute Lymphoblastic Leukemia. Translational Oncology. 13(9). 100800–100800. 10 indexed citations
11.
Kumar, Lekha Dinesh. (2019). RNA Interference and Cancer Therapy. Methods in molecular biology. 7 indexed citations
12.
Rawoof, Abdul, et al.. (2019). LeukmiR: a database for miRNAs and their targets in acute lymphoblastic leukemia. Database. 2020. 13 indexed citations
13.
Rasool, Reyaz ur, Bilal Rah, Hina Amin, et al.. (2016). Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A Novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E. Scientific Reports. 6(1). 18800–18800. 19 indexed citations
14.
Verma, Vinod Kumar, Tristan D. Clemons, Syed Sultan Beevi, et al.. (2015). RNA Interference Using c-Myc –Conjugated Nanoparticles Suppresses Breast and Colorectal Cancer Models. Molecular Cancer Therapeutics. 14(5). 1259–1269. 27 indexed citations
15.
Rah, Bilal, Reyaz ur Rasool, Debasis Nayak, et al.. (2015). PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells. Autophagy. 11(2). 314–331. 75 indexed citations
16.
Khurana, Rimpi, Vinod Kumar Verma, Abdul Rawoof, et al.. (2014). OncomiRdbB: a comprehensive database of microRNAs and their targets in breast cancer. BMC Bioinformatics. 15(1). 15–15. 28 indexed citations
17.
Kumar, Lekha Dinesh & Alan R. Clarke. (2007). Gene manipulation through the use of small interfering RNA (siRNA): From in vitro to in vivo applications. Advanced Drug Delivery Reviews. 59(2-3). 87–100. 58 indexed citations
18.
Nagaraju, Javaregowda, et al.. (2002). FISSR-PCR: a simple and sensitive assay for highthroughput genotyping and genetic mapping. Molecular and Cellular Probes. 16(1). 67–72. 20 indexed citations
19.
Kumar, Lekha Dinesh, et al.. (2001). DNA profiling of disputed chilli samples (Capsicum annum) using ISSR-PCR and FISSR-PCR marker assays. Forensic Science International. 116(1). 63–68. 45 indexed citations
20.
Kumar, Sunesh, et al.. (1998). Breast Cancer followed by Cervix cancer : a rare form of double malignancy. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Bobichon Breakdown of academic impact, for papers by Jordi Pijuan Breakdown of academic impact, for papers by David F. Moreno Breakdown of academic impact, for papers by Hongmei Wu Breakdown of academic impact, for papers by Wenyan Xu Breakdown of academic impact, for papers by Jinwei Wu Breakdown of academic impact, for papers by Anaïs Panosa Breakdown of academic impact, for papers by Xiaoyuan Zhang Breakdown of academic impact, for papers by Chenyang Li Breakdown of academic impact, for papers by Kyu-Yeon Han
Rankless by CCL
2026